Back to Authors

Baertschiger, Reto M.

https://orcid.org/0000-0002-6284-1994

Mayo Clinic

Dartmouth Health

Citations 3

Synoptic operative reports for pediatric surgical oncology
Baertschiger, Reto M. , Polites, Stephanie F. , Fusco, Joseph , Roach, Jonathan P. , Christison‐Lagay, Emily , Malek, Marcus M. , Gow, Kenneth W. , Baertschiger, Reto M , Polites, Stephanie, Malek, Marcus M , Christison-Lagay, Emily R

Pediatric Blood & Cancer | August 17, 2024 | Volume: 72 | Issue: S2 | Pages: No page available

10.1002/pbc.31280 Get It

AbstractSynoptic operative notes for pediatric surgical oncology provide standardized and structured documentation of surgical procedures performed on pediatric patients with cancer. These reports capture essential details such as preoperative diagnosis, intraoperative findings, surgical technique, and tumor characteristics in a concise and uniform format. By promoting consistency, accuracy, and completeness in reporting, synoptic operative notes facilitate effective communication among multidisciplinary healthcare teams, enhance quality assurance efforts, and streamline data extraction for research purposes. The integration of synoptic reporting within electronic medical record systems further enhances accessibility and usability, ensuring efficient documentation practices and improved patient care outcomes in pediatric surgical oncology.
Management of undifferentiated embryonal sarcoma of the liver: A Pediatric Surgical Oncology Research Collaborative study
Kastenberg, Zachary J. , Short, Scott S. , Riehle, Kimberly J. , Lautz, Timothy B. , Ott, Katherine C. , Murphy, Andrew J. , Mansfield, Sara A. , Hallis, Brian, Murphy, Joseph, Roach, Jonathan P. , Polites, Stephanie F. , Beckhorn, Catherine B , Fialkowski, Elizabeth , Seemann, Natashia M. , Bütter, Andreana , Rich, Barrie S. , Glick, Richard D. , Bondoc, Alex, Ofori-Atta, Blessing , Zamora, Abigail K., Vasudevan, Sanjeev A. , Rinehardt, Hannah , Lapidus‐Krol, Eveline , Meyers, Rebecka L. , Tiao, Greg , Dasgupta, Roshni , Baertschiger, Reto M. , Lautz, Timothy , Murphy, Andrew J , Beckhorn, Catherine , Tracy, Elisabeth T , Fialkowski, Elizabeth A , Seemann, Natashia M , Malek, Marcus M , Baertschiger, Reto , Kastenberg, Zachary J , Dasgupta, Roshni , Utria, Alan Fremder , Lal, Dave R. , Tracy, Elisabeth T. , Bondoc, Alexander , Presson, Angela P. , Chen, Stephanie , Kim, Eugene S. , Malek, Marcus M. , Putra, Juan , Superina, Riccardo Antonio , Langham, Max Raymond

Pediatric Blood & Cancer | April 1, 2024 | Volume: 71 | Issue: 6 | Pages: No page available

10.1002/pbc.30975 Get It

AbstractBackgroundUndifferentiated embryonal sarcoma of the liver (UESL) is a rare tumor for which there are few evidence‐based guidelines. The aim of this study was to define current management strategies and outcomes for these patients using a multi‐institutional dataset curated by the Pediatric Surgical Oncology Research Collaborative.MethodsData were collected retrospectively for patients with UESL treated across 17 children's hospitals in North America from 1989 to 2019. Factors analyzed included patient and tumor characteristics, PRETEXT group, operative details, and neoadjuvant/adjuvant regimens. Event‐free and overall survival (EFS, OS) were the primary and secondary outcomes, respectively.ResultsSeventy‐eight patients were identified with a median age of 9.9 years [interquartile range [IQR): 7–12]. Twenty‐seven patients underwent resection at diagnosis, and 47 patients underwent delayed resection, including eight liver transplants. Neoadjuvant chemotherapy led to a median change in maximum tumor diameter of 1.6 cm [IQR: 0.0–4.4] and greater than 90% tumor necrosis in 79% of the patients undergoing delayed resection. R0 resections were accomplished in 63 patients (81%). Univariate analysis found that metastatic disease impacted OS, and completeness of resection impacted both EFS and OS, while multivariate analysis revealed that R0 resection was associated with decreased expected hazards of experiencing an event [hazard ratio (HR): 0.14, 95% confidence interval (CI): 0.04–0.6]. At a median follow‐up of 4 years [IQR: 2–8], the EFS was 70.0% [95% CI: 60%–82%] and OS was 83% [95% CI: 75%–93%].ConclusionComplete resection is associated with improved survival for patients with UESL. Neoadjuvant chemotherapy causes minimal radiographic response, but significant tumor necrosis.
Patient and Process Outcomes among Pediatric Patients Undergoing Appendectomy during the COVID-19 Pandemic: An International Retrospective Cohort Study
Matava, Clyde , Tighe, Nathaniel T. G. , Baertschiger, Reto M. , Wilder, Robert T., Correll, Lynnie , Staffa, Steven J. , Kato, Meredith , Meier, Petra M. , Raman, Vidya T. , Roque, Remigio A. , Zhong, John , Edala, Thejovathi , Greer, Timothy J. , Ungern‐Sternberg, Britta S. von , Simpao, Allan F. , Collaborators, for the PEACOC, Zurakowski, David , Reddy, Srijaya K. , Peterson, Melissa Brooks , Cravero, Joseph P. , Collaborators, for the PEACOC

Anesthesiology | April 4, 2023 | Volume: 139 | Issue: 1 | Pages: 35-48

10.1097/aln.0000000000004570 Get It

Background COVID-19 forced healthcare systems to make unprecedented changes in clinical care processes. The authors hypothesized that the COVID-19 pandemic adversely impacted timely access to care, perioperative processes, and clinical outcomes for pediatric patients undergoing primary appendectomy. Methods A retrospective, international, multicenter study was conducted using matched cohorts within participating centers of the international PEdiatric Anesthesia COVID-19 Collaborative (PEACOC). Patients younger than 18 yr old were matched using age, American Society of Anesthesiologists Physical Status, and sex. The primary outcome was the difference in hospital length of stay of patients undergoing primary appendectomy during a 2-month period early in the COVID-19 pandemic (April to May 2020) compared with prepandemic (April to May 2019). Secondary outcomes included time to appendectomy and the incidence of complicated appendicitis. Results A total of 3,351 cases from 28 institutions were available with 1,684 cases in the prepandemic cohort matched to 1,618 in the pandemic cohort. Hospital length of stay was statistically significantly different between the two groups: 29 h (interquartile range: 18 to 79) in the pandemic cohort versus 28 h (interquartile range: 18 to 67) in the prepandemic cohort (adjusted coefficient, 1 [95% CI, 0.39 to 1.61]; P < 0.001), but this difference was small. Eight centers demonstrated a statistically significantly longer hospital length of stay in the pandemic period than in the prepandemic period, while 13 were shorter and 7 did not observe a statistically significant difference. During the pandemic period, there was a greater occurrence of complicated appendicitis, prepandemic 313 (18.6%) versus pandemic 389 (24.1%), an absolute difference of 5.5% (adjusted odds ratio, 1.32 [95% CI, 1.1 to 1.59]; P = 0.003). Preoperative SARS-CoV-2 testing was associated with significantly longer time-to-appendectomy, 720 min (interquartile range: 430 to 1,112) with testing versus 414 min (interquartile range: 231 to 770) without testing, adjusted coefficient, 306 min (95% CI, 241 to 371; P < 0.001), and longer hospital length of stay, 31 h (interquartile range: 20 to 83) with testing versus 24 h (interquartile range: 14 to 68) without testing, adjusted coefficient, 7.0 (95% CI, 2.7 to 11.3; P = 0.002). Conclusions For children undergoing appendectomy, the COVID-19 pandemic did not significantly impact hospital length of stay. Editor’s Perspective What We Already Know about This Topic What This Article Tells Us That Is New